PHOENIX, Arizona--ViziLite Plus with TBlue630, the emerging standard of care for the early detection of oral abnormalities that could lead to cancer, now includes Pearlescent retractors.
These retractors replace earlier transparent devices. With an opaque backside, the new retractors focus more light on the oral cavity, and block light from shining directly back at the clinician.
"Dentists are having considerable success with ViziLite Plus," said David Barshis, vice president and general manager of Zila Pharmaceuticals. "We are delighted to respond to their feedback with our new Pearlescent retractor, advancing this exciting, effective technology."
Scottsdale, Ariz., dentist Paul Douglas has been using ViziLite Plus extensively. "My patients really appreciate the ViziLite Plus exam," he said. "I provide it as part of nearly all routine annual exams. On several occasions, ViziLite helped identify areas of concern that otherwise would have been difficult, if not impossible, to find."
ViziLite Plus is available from Pro-Dentec sales representatives and Zila Pharmaceuticals customer service representatives. Information is available at ViziLite, or (800) 922-7887.
